turn
Gulou District, Nanjing
Biomedical industry is in full swing
Two representative companies in the region
--Nanjing Hanxing Information Technology Co.
With Jiangsu Chuangyuan Life Science and Technology Co.
Recently closed a new round of important financing back-to-back
Demonstrates the different development models in the
Strong Innovation Vitality and Market Recognition
A good start to the year's industrial development
Among them, Nanjing Hanxing Information Technology Co., Ltd. is the leading pet medical supply chain service platform in China, with business covering nearly 50,000 pet medical service terminals across the country.
In recent years, the development momentum of the enterprise continues to improve, the core B2B platform "Veterinarian Preferred" and its own brand "Bespoken" has achieved a large-scale layout in the pet medicine market, and the business scope is gradually expanding to Southeast Asia and other overseas markets.
The company has recently successfully completed the B+ round of financing, with investors including main board listed companies. This round of financing will strongly promote the construction of its own brand production line and market expansion, and provide solid support for the enterprise to move towards the goal of higher level capital market.
Jiangsu Chuangyuan Life Science and Technology Co., Ltd. is a good example of Gulou District's "School-Land-Enterprise-Financial" deep integration model. As a hard science and technology enterprise incubated on the innovation transformation platform jointly built by Gulou District and China Pharmaceutical University, it focuses on the research and development of therapeutic mRNA drugs for hepatitis B, and has recently successfully completed a financing of more than 60 million yuan.
The funding will be used to accelerate the global clinical trial submission of its first new drug, which fully verifies the effectiveness of the precise transformation pathway of "university originality-platform incubation-capital empowerment".
The successive favor of capital is a reflection of the strength of innovative enterprises, but also a "vote" for a regional systematic innovation ecology. In recent years, Gulou District systematic layout, in-depth cultivation, through the "one school, one product, one special, one park" mechanism to fully activate the resources of colleges and universities, has formed a digital, health, green and other areas of the "matrix of innovation". The financing of Jiangsu Chuangyuan Life is a vivid epitome of this matrix in the health economy track.
This is the most intensive "mine" of innovation resources.
The 7 universities involved in medicine, 11 drug clinical trial organizations and 12 tertiary hospitals are highly concentrated here, which builds the shortest path for biomedical innovation from target discovery at source to clinical validation.
Here is the most professional school-land co-education platform
In the field of health economy, Gulou District and Nanjing University, Gulou Hospital to build a brain-computer interface research institute, and Nanjing Normal University to build an intelligent biological manufacturing innovation center, and China Pharmaceutical University to build the Institute of Translational Medicine, for cutting-edge technology from the laboratory to the market to build a solid "ladder".
The capital empowerment system has been constructed here in chronological succession
In order to open up the capital chain of "research-transformation-industry", Gulou District is accelerating the construction of a relay-type financial network covering the whole life cycle of the project, through the whole process of innovation from "sowing" to "harvesting". Gulou District is accelerating the construction of a relay financial network covering the whole life cycle of the project, through the whole process of innovation from "sowing" to "harvesting. In the early stage of project concept verification, Gulou District focuses on introducing and participating in the Nanjing Biomedical Proof of Concept Fund with a total scale of 300 million yuan. The fund is actively oriented to the selection of high-quality projects in the early stage of the country, and its first investment will be accurate in Gulou - invested in Jiangsu Chuangyuan Life Science and Technology Company Limited, which effectively cracked the original innovation "from 0 to 0.5" of the early financing problems for the transformation of the results of this stage. Ltd. effectively solved the problem of financing in the early stage of "from 0 to 0.5" of original innovation, and verified the efficient path for the transformation of the achievements in this stage. In order to strengthen the ability to undertake local scientific research results, Gulou District is joining hands with China Pharmaceutical University, Minmetals Securities and other companies to build a complete fund support chain running through the stages of "proof of concept - R&D and transformation - industrial expansion", so as to accurately match the capital water for innovative projects at different stages. Capital water.
The most suitable carriers and precise services are available here.
A number of specialized carriers, such as the Ring Pharmaceutical Cluster, the Brain-Machine-Intelligence Technology Park, and the Shufu Zhigu Biotechnology Innovation Park, provide enterprises with "turnkey" R&D space. Gulou District launched a series of brand activities such as "Medical Drums", which provides one-stop services for biomedical enterprises from technology matching to financing referrals.
Nurtured by the unique resource endowment and all-round accurate services, the development of life and health industry in Gulou District has begun to show results. On the one hand, the strong growth momentum of the local leading enterprises represented by Lingtong Medicine and NuBang Bio, driving the overall industrial scale to continue to improve, and the revenue of life and health enterprises in the region to achieve double-digit growth in 2025; on the other hand, a number of high-quality projects have been attracted to land in the area, such as Jingdong Health and Jixi Sikai, which further strengthen the industrial chain, make up for the key links, and extend the value of industry, injecting new development momentum and vitality into the life and health industry in the region. Life and health industry has injected new development momentum and vitality.
The financing breakthrough of the two enterprises is not only a key step in their own development process, but also a milestone in the systematic construction of industrial ecology in Gulou District, which provides vivid practical support for exploring the efficient transformation mode of science and education resources in the main urban area with the core of "Nanjing Biomedical R&D and Transformation Center". In the next step, Gulou District will continue to base on its own advantages, to promote more university-land cooperation results to take root, so that more excellent laboratory results, under the precise drip irrigation of capital water, steadily complete the growth from the technology germ to the industrial embryonic leap, for Nanjing to build a global biomedical innovation city continue to contribute Gulou strength.
